Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)
Authors:
- 22 July 2015
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 20 (2) , 284-293
Abstract
In Fabry disease, progressive glycolipid accumulation leads to damage in kidney and other organs. This study was designed to determine the prevalence rate of Fabry disease in Japanese dialysis patients.Keywords
This publication has 35 references indexed in Scilit:
- Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot studyJournal of Human Genetics, 2013
- Long‐term outcome of enzyme‐replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complicationsJournal of Internal Medicine, 2013
- The frequency of Fabry disease with the E66Q variant in the ?-galactosidase A gene in Japanese dialysis patients: a case report and a literature reviewClinical Nephrology, 2012
- Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patientsOrphanet Journal of Rare Diseases, 2011
- Le diagnostic de la maladie de Fabry : intérêt de l’enquête cliniqueLa Revue de Médecine Interne, 2010
- Frequency of Fabry disease in male and female haemodialysis patients in SpainBMC Medical Genetics, 2010
- Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapyNephrology Dialysis Transplantation, 2009
- Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotesPediatric Nephrology, 2008
- dentification of Fabry’s disease by the screening of a-galactosidase A activity in male and female hemodialysis patientsClinical Nephrology, 2005
- Significance of screening for Fabry disease among male dialysis patientsClinical and Experimental Nephrology, 2005